ginet
rex medical ltd - cyproterone acetate 2mg; ; ; ethinylestradiol 0.035mg; - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: hypromellose lactose monohydrate magnesium stearate povidone propylene glycol purified talc quinoline yellow starch titanium dioxide colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose propylene glycol purified talc starch titanium dioxide - androgen-dependent diseases in women are an indication for treatment with ginet. these diseases may include: acne (where local treatment or oral antibiotics alone have not been successful), especially pronounced forms of acne that may be accompanied by inflammation or formation of nodes (acne nodulocystica, acne papulopustulosa), seborrhea, mild forms of hirsutism and/or androgenic alopecia. oral contraception in women requiring treatment for these androgen-dependent diseases is an indication for treatment with ginet. however ginet is not recommended in women solely for contraception. it should not be used in combination with other hormonal contraceptives. ginet is indicated for the relief of symptoms of polycystic ovary syndrome.
estelle-35 ed
douglas pharmaceuticals limited - cyproterone acetate 2mg; ; ethinylestradiol 0.035mg; - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b opaglos white 6000 povidone purified water quinoline yellow sucrose lactose monohydrate magnesium stearate microcrystalline cellulose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.
diane-35 ed
bayer new zealand limited - cyproterone acetate 2mg; ethinylestradiol 0.035mg - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sucrose titanium dioxide calcium carbonate glycol montanate lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone purified talc sucrose - · the treatment of signs of androgenisation in women, such as severe acne (involving inflammation or nodularity or risk of scarring) where prolonged oral antibiotics or local treatment alone has not been successful, or idiopathic hirsutism of mild to moderate degree.
claudia-35 2 mg - 0,035 mg coat. tabl.
sandoz sa-nv - ethinylestradiol 0,035 mg; cyproterone acetate 2 mg - coated tablet - 2 mg - 0,035 mg - cyproterone acetate 2 mg; ethinylestradiol 35 µg - cyproterone and estrogen
claudia-35 2 mg - 0,035 mg coat. tabl.
sandoz sa-nv - ethinylestradiol 0,035 mg; cyproterone acetate 2 mg - coated tablet - 2 mg - 0,035 mg - cyproterone acetate 2 mg; ethinylestradiol 35 µg - cyproterone and estrogen
daphne 2 mg - 0,035 mg coat. tabl.
ceres pharma sa-nv - ethinylestradiol 0,035 mg; cyproterone acetate 2 mg - coated tablet - 2 mg - 0,035 mg - cyproterone acetate 2 mg; ethinylestradiol 35 µg - cyproterone and estrogen
elisaviatris 2 mg - 0.035 mg coat. tabl.
viatris gx bv-srl - ethinylestradiol 0,035 mg; cyproterone acetate 2 mg - coated tablet - 2 mg - 0,035 mg - cyproterone acetate 2 mg; ethinylestradiol 35 µg - cyproterone and estrogen
diane-35 2 mg/0.035 mg coat. tabl.
bayer sa-nv - ethinylestradiol 0,035 mg; cyproterone acetate 2 mg - coated tablet - 2 mg - 0,035 mg - ethinylestradiol 35 µg; cyproterone acetate 2 mg - cyproterone and estrogen
estelle-35
douglas pharmaceuticals limited - cyproterone acetate 2mg; ; ethinylestradiol 0.035mg; - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: croscarmellose sodium opaglos 6000 white lactose monohydrate magnesium stearate microcrystalline cellulose opadry buff oy-3690 opadry white y-1r-7000b povidone purified water quinoline yellow sucrose - estelle-35 and estelle-35 ed are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. estelle-35 and estelle-35 ed are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. estelle-35 and estelle-35 ed are also indicated for treating the symptoms of polycystic ovary syndrome.
ginet 63
rex medical ltd - cyproterone acetate 2mg; ; ; ethinylestradiol 0.035mg; - film coated tablet - active: cyproterone acetate 2mg ethinylestradiol 0.035mg excipient: hypromellose lactose monohydrate magnesium stearate povidone propylene glycol purified talc quinoline yellow starch titanium dioxide - androgen-dependent diseases in women are an indication for treatment with ginet-63. these diseases may include: acne (where local treatment or oral antibiotics alone have not been successful), especially pronounced forms of acne that may be accompanied by inflammation or formation of nodes (acne nodulocystica, acne papulopustulosa), seborrhea, mild forms of hirsutism and/or androgenic alopecia. oral contraception in women requiring treatment for these androgen-dependent diseases is an indication for treatment with ginet-63. however ginet-63 is not recommended in women solely for contraception.